Last reviewed · How we verify

E39 vaccine then J65 vaccine

COL George Peoples, MD, FACS · Phase 1 active Biologic

E39 vaccine then J65 vaccine is a Biologic drug developed by COL George Peoples, MD, FACS. It is currently in Phase 1 development. Also known as: J65 peptide (EIWTFSTKV, Folate Binding Protein), GM-CSF (Sargramostim), E39 peptide (EIWTHSYKV, Folate Binding Protein, 191-199).

At a glance

Generic nameE39 vaccine then J65 vaccine
Also known asJ65 peptide (EIWTFSTKV, Folate Binding Protein), GM-CSF (Sargramostim), E39 peptide (EIWTHSYKV, Folate Binding Protein, 191-199)
SponsorCOL George Peoples, MD, FACS
ModalityBiologic
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about E39 vaccine then J65 vaccine

What is E39 vaccine then J65 vaccine?

E39 vaccine then J65 vaccine is a Biologic drug developed by COL George Peoples, MD, FACS.

Who makes E39 vaccine then J65 vaccine?

E39 vaccine then J65 vaccine is developed by COL George Peoples, MD, FACS (see full COL George Peoples, MD, FACS pipeline at /company/col-george-peoples-md-facs).

Is E39 vaccine then J65 vaccine also known as anything else?

E39 vaccine then J65 vaccine is also known as J65 peptide (EIWTFSTKV, Folate Binding Protein), GM-CSF (Sargramostim), E39 peptide (EIWTHSYKV, Folate Binding Protein, 191-199).

What development phase is E39 vaccine then J65 vaccine in?

E39 vaccine then J65 vaccine is in Phase 1.

Related